Use of Real-World Electronic Health Records to Estimate Risk, Risk Factors, and Disparities for COVID-19 in Patients With Cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
JAMA Oncology, sous presse, 2020, commentaire en libre accès
Résumé en anglais
The coronavirus disease 2019 (COVID-19) pandemic has introduced additional serious risks for patients with cancer and is deeply affecting current cancer care. Early data from observational studies have suggested high rates of hospitalization and early mortality.1 However, even more granular data are needed to identify specific populations with cancer at greatest risk of serious outcomes from COVID-19, as well as to understand the risk factors that predispose patients to develop COVID-19.